Johanna K. DiStefano
机构: Professor and Head, Diabetes and Fibrotic Disease Research Unit, Translational Genomics Research Unit
每年引用次数
引用次数
引用: 5,960
H-指数: 40
I10-指数 : 82
出版物: 154
Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation.
H.A. Chakkera , R.L. Hanson , S.M. Raza , J.K. DiStefano
Transplantation proceedings 41 ( 10) 4172 -4177
30
2009
Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes.
D. W. Craig , M. P. Millis , J. K. DiStefano
Diabetic Medicine 26 ( 11) 1090 -1098
56
2009
Towards microRNA-based therapeutics for diabetic nephropathy.
M. L. Alvarez , J. K. DiStefano
Diabetologia 56 ( 3) 444 -456
22
2013
Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma.
Johanna DiStefano , Bethany Davis
Cancers 11 ( 4) 486
19
2019
Identification of Novel Clinical Factors Associated with Hepatic Fat Accumulation in Extreme Obesity
Benotti Peter , Wood G Craig , Chu Xin , Argyropoulos George
Journal of Obesity 2014 368210 -368210
14
2014
The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD).
Amanda Hanson , Danielle Wilhelmsen , Johanna DiStefano
Non-Coding RNA 4 ( 3) 18
48
2018
Genome-wide analysis identifies loci associated with total bilirubin levels, steatosis, and mild fibrosis in nonalcoholic fatty liver disease: 588
Johanna DiStefano , Christopher Kingsley , Christopher D Still , Stefania Cotta Don
Hepatology 58 488A -489A
2013
Research Article Identification of Novel Clinical Factors Associated with Hepatic Fat Accumulation in Extreme Obesity
Glenn S Gerhard , Peter Benotti , G Craig Wood , Xin Chu
CXCL4L1 Promoter Polymorphisms Are Associated with Improved Renal Function in Type 1 Diabetes.
Tabea Armbrust , Meredith Paige Millis , Maria Lucrecia Alvarez , Aramesh Saremi
Journal of Immunology 202 ( 3) 912 -919
2019
Differential Effects of Multiplicity of Infection on Helicobacter pylori-Induced Signaling Pathways and Interleukin-8 Gene Transcription
Birgit Ritter , Petra Kilian , Marc Rene Reboll , Klaus Resch
Journal of Clinical Immunology 31 ( 1) 60 -68
17
2011
2119-P: AKR1B10 Is Upregulated in Nonalcoholic Fatty Liver Disease and Is Regulated by Fatty Acid Loading in Hepatocytes and Hepatic Stellate Cells
BETHANY DAVIS , DANIELLE M. WILHELMSEN , AMANDA HANSON , JOHANNA DISTEFANO
Diabetes 68
2019
166-LB: Clinical Improvements and Extracellular Vesicle Size following Lifestyle Intervention in Latino Youth with Nonalcoholic Fatty Liver Disease
IGNAZIO PIRAS , XIUMEI WU , PATRICK PIRROTTE , MICAH OLSON
Diabetes 72 ( Supplement_1)
2023
Perimenopausal Obesity
Colleen Keller , Linda Larkey , Johanna K. Distefano , Edna Boehm-Smith
Journal of Women's Health 19 ( 5) 987 -996
2010
Acknowledgement to Reviewers of the Journal of Personalized Medicine in 2014
Journal of Personalized Medicine Editorial Office ,
Journal of Personalized Medicine 5 ( 1) 1 -2
2
2015
Identification of Novel Loci Associated with Response to Pioglitazone zone in the PIPOD Study
Johanna K Distefano , Kimberly A Yeatts , Mohamed T Hassanein , Anny H Xiang
DIABETES 58 A308 -A308
2009
Rac1 Activation by High Glucose Is Mediated by ELMO1 in Kidney Cells
Stefania Cotta-Done , Serdar Tuncali , Julianna Ross , Nhan L Tran
DIABETES 60 A171 -A171
2011
Characterization of microRNAs derived from the plasmacytoma variant translocation 1 gene (PVT1) as mediator of diabetic kidney disease
M Lucrecia Alvarez , Jeff Kiefer , Johanna K Distefano
Diabetes 60 A164 -A164
1
2011
Effects of dietary sugar restriction on hepatic fat in youth with obesity.
Johanna K Distefano , Glenn S Gerhard
Minerva Pediatrics
2
2023
Characterization of the Plasmacytoma Variant Translocation 1 Gene (PVT1) as a Mediator of Diabetic Kidney Disease
M Lucrecia Alvarez , Johanna K Distefano
DIABETES 59 A1 -A2
2010
Genetic Variation in Peroxisome Proliferator-Activated Receptor-gamma Co-Activator 1 beta (PPARGC1B) and Cytochrome p450 3A4 (CYP3A4) Are Associated with Response to Pioglitazone Therapy
Mohamed T Hassanein , Anny H Xiang , Kimberly A Yeatts , Thomas A Buchanan
DIABETES 58 A307 -A307
2009